Immediate Release
                                                     30 November 2009

                       ReGen Therapeutics Plc
                      ('ReGen' or the Company')
                         Total Voting Rights

For the  purposes of  the Disclosure  and Transparency  Rules of  the
Financial Services  Authority,  the Board  of  ReGen is  required  to
notify the market of the following:

As at  the date  of  this announcement,  the Company's  issued  share
capital consists of 36,729,882 ordinary  shares with a nominal  value
of 0.01 p each, with  voting rights ("Ordinary Shares"). The  Company
does not hold any Ordinary Shares in Treasury.

Therefore the total  number of  Ordinary Shares in  the Company  with
voting rights is 36,729,882.

The above  figure  of  36,729,882  Ordinary Shares  may  be  used  by
shareholders in the Company as  the denominator for the  calculations
by which they  will determine if  they are required  to notify  their
interest in, or a change to  their interest in, the share capital  of
the Company under  the Financial Service  Authority's Disclosure  and
Transparency Rules.


ENDS

For further information:
Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920

Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel: 020 7628 3396

---END OF MESSAGE---




This announcement was originally distributed by Hugin. The issuer is 
solely responsible for the content of this announcement.


Copyright © Hugin AS 2009. All rights reserved.